A shadow economy for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to recent findings.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are encouraged to contact these accounts privately for source information, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on messaging services, where groups with thousands of members share comparison photos, administration instructions and assertions of next-day British shipping. Vendors promote the drug there before directing customers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to 25% of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is worrisome and could result in individuals injecting products of unknown origin.
Several professionals said the demand for the experimental drug could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations.
Several content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still breach medicines, marketing, and consumer regulations, potentially leading to fines, legal action or imprisonment.
Service Response and Content Removal
According to the social media company, the platform has taken down problematic content and banned associated keywords and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening enforcement strategies.
Online Trading Activities
Investigations also discovered communities with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, filled with images of weight loss, glowing reviews and step-by-step instructions for mixing or administering at residence.
Within minutes of entering one community, a vendor shared contact information, where most purchases take place. The seller provided an guidebook and guaranteed delivery within two days. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one asked about body mass, medical conditions or past usage.
Product Information and Pricing
Inside these groups, messages show dark colored packages with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how long a injector should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Security Measures
A representative for Telegram said it actively moderated harmful content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they can’t verify. Even if the research behind retatrutide is sound, these online versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor connected the surge in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are using online platforms. But counterfeit injections are highly dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.
Her staff has already encountered patients harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company said the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company experimental substance not yet authorized … may expose patients to potentially serious health risks”.
